Surgery Today

, Volume 48, Issue 2, pp 180–185 | Cite as

Long-term outcomes of laparoscopic versus open splenectomy for immune thrombocytopenia

  • Kazuhiro Tada
  • Masayuki Ohta
  • Kunihiro Saga
  • Hiroomi Takayama
  • Teijiro Hirashita
  • Yuichi Endo
  • Hiroki Uchida
  • Yukio Iwashita
  • Masafumi Inomata
Original Article
First Online:
Received:
Accepted:

Abstract

Purpose

Splenectomy is the standard therapy for medically refractory immune thrombocytopenia (ITP). Laparoscopic splenectomy (LS) has gained wide acceptance; however, the long-term outcomes of LS versus open splenectomy (OS) for patients with ITP remain unclear.

Methods

We analyzed, retrospectively, 32 patients who underwent splenectomy, as LS in 22 and OS in 10, for refractory ITP at our institute. Data were evaluated based on the American Society of Hematology 2011 evidence-based practice guidelines for ITP.

Results

Although the operation time was significantly longer in the LS group (p < 0.01), LS was associated with less blood loss (p < 0.01), infrequent blood transfusion during surgery (p < 0.01), quicker resumption of oral intake (p < 0.01), and shorter hospital stay (p < 0.01) than OS. Positive responses, including complete and partial remission, were achieved in 90% of the OS group patients and 77% of the LS group patients. The mean follow-up periods were 183 and 92 months, respectively. Relapse-free survival rates, 15 years after the operation were 63% in the OS group and 94% in the LS group.

Conclusions

LS can provide better short-term results and comparable long-term results to those of OS for ITP.

Keywords

Immune thrombocytopenia Laparoscopic splenectomy Short-term outcomes Long-term outcomes 
This is a preview of subscription content, log in to check access.

Notes

Compliance with ethical standards

Conflict of interest

We declare that we have no conflicts of interest and that no sources of funding or material support were provided for this study.

References

  1. 1.
    Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386–93.CrossRefPubMedGoogle Scholar
  2. 2.
    Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–86.CrossRefPubMedGoogle Scholar
  3. 3.
    Chater C, Terriou L, Duhamel A, Launay D, Chambon JP, Pruvot FR, et al. Reemergence of splenectomy for ITP second-line treatment? Ann Surg. 2016;264:772–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004;104:2623–34.CrossRefPubMedGoogle Scholar
  5. 5.
    Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, et al. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Haematologica. 2005;90:72–7.PubMedGoogle Scholar
  6. 6.
    Lefor AT, Melvin WS, Bailey RW, Flowers JL. Laparoscopic splenectomy in the management of immune thrombocytopenia purpura. Surgery. 1993;114:613–8.PubMedGoogle Scholar
  7. 7.
    Gigot JF, Healy ML, Ferrant A, Michaux JL, Njinou B, Kestens PJ. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Br J Surg. 1994;81:1171–2.CrossRefPubMedGoogle Scholar
  8. 8.
    Hashizume M, Sugimachi K, Kitano S, Shimada M, Baba H, Ueno K, et al. Laparoscopic splenectomy. Am J Surg. 1994;167:611–4.CrossRefPubMedGoogle Scholar
  9. 9.
    Watson DI, Coventry BJ, Chin T, Gill PG, Malycha P. Laparoscopic versus open splenectomy for immune thrombocytopenic purpura. Surgery. 1997;121:18–22.CrossRefPubMedGoogle Scholar
  10. 10.
    Lozano-Salazar RR, Herrera MF, Vargas-Vorackova F, Lopez-Karpovitch X. Laparoscopic versus open splenectomy for immune thrombocytopenic purpura. Am J Surg. 1998;176:366–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Tanoue K, Hashizume M, Morita M, Migoh S, Tsugawa K, Yagi S, et al. Results of laparoscopic splenectomy for immune thrombocytopenic purpura. Am J Surg. 1999;177:222–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Winslow ER, Brunt LM. Perioperative outcomes of laparoscopic versus open splenectomy: a meta-analysis with an emphasis on complications. Surgery. 2003;134:647–53 (discussion 54–5).CrossRefPubMedGoogle Scholar
  13. 13.
    Friedman RL, Fallas MJ, Carroll BJ, Hiatt JR, Phillips EH. Laparoscopic splenectomy for ITP. The gold standard. Surg Endosc. 1996;10:991–5.CrossRefPubMedGoogle Scholar
  14. 14.
    Sampath S, Meneghetti AT, MacFarlane JK, Nguyen NH, Benny WB, Panton ON. An 18-year review of open and laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Am J Surg. 2007;193:580–3 (discussion 3–4).CrossRefPubMedGoogle Scholar
  15. 15.
    Wu JM, Lai IR, Yuan RH, Yu SC. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Am J Surg. 2004;187:720–3.CrossRefPubMedGoogle Scholar
  16. 16.
    Qu Y, Xu J, Jiao C, Cheng Z, Ren S. Long-term outcomes of laparoscopic splenectomy versus open splenectomy for idiopathic thrombocytopenic purpura. Int Surg. 2014;99:286–90.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Vecchio R, Marchese S, Intagliata E, Swehli E, Ferla F, Cacciola E. Long-term results after splenectomy in adult idiopathic thrombocytopenic purpura: comparison between open and laparoscopic procedures. J Laparoendosc Adv Surg Tech A. 2013;23:192–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Rijcken E, Mees ST, Bisping G, Krueger K, Bruewer M, Senninger N, et al. Laparoscopic splenectomy for medically refractory immune thrombocytopenia (ITP): a retrospective cohort study on longtime response predicting factors based on consensus criteria. Int J Surg. 2014;12:1428–33.CrossRefPubMedGoogle Scholar
  19. 19.
    Xu T, Li N, Jin F, Wu K, Ye Z. Predictive factors of idiopathic thrombocytopenic purpura and long-term survival in Chinese adults undergoing laparoscopic splenectomy. Surg Laparosc Endosc Percutan Tech. 2016;26:397–400.CrossRefPubMedGoogle Scholar
  20. 20.
    Ohta M, Nishizaki T, Matsumoto T, Shimabukuro R, Sasaki A, Shibata K, et al. Analysis of risk factors for massive intraoperative bleeding during laparoscopic splenectomy. J Hepatobiliary Pancreat Surg. 2005;12:433–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190–207.CrossRefPubMedGoogle Scholar
  22. 22.
    Tsiotos G, Schlinkert RT. Laparoscopic splenectomy for immune thrombocytopenic purpura. Arch Surg. 1997;132:642–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Duperier T, Brody F, Felsher J, Walsh RM, Rosen M, Ponsky J. Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura. Arch Surg. 2004;139:61–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Mikhael J, Northridge K, Lindquist K, Kessler C, Deuson R, Danese M. Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: a systematic review. Am J Hematol. 2009;84:743–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Chang M, Nakagawa PA, Williams SA, Schwartz MR, Imfeld KL, Buzby JS, et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood. 2003;102:887–95.CrossRefPubMedGoogle Scholar
  26. 26.
    McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2004;103:1364–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Koshenkov VP, Pahuja AK, Nemeth ZH, Abkin A, Carter MS. Identification of accessory spleens during laparoscopic splenectomy is superior to preoperative computed tomography for detection of accessory spleens. JSLS. 2012;16:387–91.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Budzynski A, Bobrzynski A, Sacha T, Skotnicki A. Laparoscopic removal of retroperitoneal accessory spleen in patient with relapsing idiopathic thrombocytopenic purpura 30 years after classical splenectomy. Surg Endosc. 2002;16:1636.CrossRefPubMedGoogle Scholar
  29. 29.
    Napoli A, Catalano C, Silecchia G, Fabiano P, Fraioli F, Pediconi F, et al. Laparoscopic splenectomy: multi-detector row CT for preoperative evaluation. Radiology. 2004;232:361–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Quah C, Ayiomamitis GD, Shah A, Ammori BJ. Computed tomography to detect accessory spleens before laparoscopic splenectomy: is it necessary? Surg Endosc. 2011;25:261–5.CrossRefPubMedGoogle Scholar
  31. 31.
    Habermalz B, Sauerland S, Decker G, Delaitre B, Gigot JF, Leandros E, et al. Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2008;22:821–48.CrossRefPubMedGoogle Scholar
  32. 32.
    Imbach P, Barandun S, d’Apuzzo V, Baumgartner C, Hirt A, Morell A, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981;1:1228–31.CrossRefPubMedGoogle Scholar
  33. 33.
    Bussel JB. The use of intravenous gamma-globulin in idiopathic thrombocytopenic purpura. Clin Immunol Immunopathol. 1989;53:S147–55.CrossRefPubMedGoogle Scholar
  34. 34.
    Imbach P, Wagner HP, Berchtold W, Gaedicke G, Hirt A, Joller P, et al. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet. 1985;2:464–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med. 1982;306:1254–8.CrossRefPubMedGoogle Scholar
  36. 36.
    Bussel JB, Kimberly RP, Inman RD, Schulman I, Cunningham-Rundles C, Cheung N, et al. Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood. 1983;62:480–6.PubMedGoogle Scholar
  37. 37.
    Abe T, Matsuda J, Kawasugi K, Yoshimura Y, Kinoshita T, Kazama M. Clinical effect of intravenous immunoglobulin on chronic idiopathic thrombocytopenic purpura. Blut. 1983;47:69–75.CrossRefPubMedGoogle Scholar
  38. 38.
    Hamabe A, Omori T, Oyama T, Akamatsu H, Yoshidome K, Tori M, et al. A case of Helicobacter pylori infection complicated with gastric cancer, gastric mucosa-associated lymphoid tissue lymphoma, and idiopathic thrombocytopenic purpura successfully treated with laparoscopy-assisted total gastrectomy and splenectomy. Asian J Endosc Surg. 2011;4:32–5.CrossRefPubMedGoogle Scholar
  39. 39.
    Suzuki T, Matsushima M, Masui A, Watanabe K, Takagi A, Ogawa Y, et al. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura—a randomized controlled trial. Am J Gastroenterol. 2005;100:1265–70.CrossRefPubMedGoogle Scholar
  40. 40.
    Fujimura K, Kuwana M, Kurata Y, Imamura M, Harada H, Sakamaki H, et al. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol. 2005;81:162–8.CrossRefPubMedGoogle Scholar
  41. 41.
    Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med. 2007;146:25–33.CrossRefPubMedGoogle Scholar
  42. 42.
    Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008;371:395–403.CrossRefPubMedGoogle Scholar
  43. 43.
    Bussel JB, Cheng G, Saleh MN, Psaila B, Kovaleva L, Meddeb B, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med. 2007;357:2237–47.CrossRefPubMedGoogle Scholar
  44. 44.
    Palandri F, Polverelli N, Catani L, Sollazzo D, Romano M, Levorato M, et al. The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study. Am J Hematol. 2014;89:1047–50.CrossRefPubMedGoogle Scholar
  45. 45.
    Ghanima W, Godeau B, Cines DB, Bussel JB. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood. 2012;120:960–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Japan KK 2017

Authors and Affiliations

  • Kazuhiro Tada
    • 1
  • Masayuki Ohta
    • 1
  • Kunihiro Saga
    • 1
  • Hiroomi Takayama
    • 1
  • Teijiro Hirashita
    • 1
  • Yuichi Endo
    • 1
  • Hiroki Uchida
    • 1
  • Yukio Iwashita
    • 1
  • Masafumi Inomata
    • 1
  1. 1.Department of Gastroenterological and Pediatric SurgeryOita University Faculty of MedicineOitaJapan

Personalised recommendations